Tylophoside C

Details

Top
Internal ID 7c453799-fcc7-49b6-aa54-5ecea4f5af7a
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Oligosaccharides
IUPAC Name (4S,5R,7R,8R,13R,16S,19R,22R)-7-hydroxy-8-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6S)-5-[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.04,13.05,10.019,22]docosa-1(21),10-dien-14-one
SMILES (Canonical) CC1C(C(CC(O1)OC2C(OC(CC2OC)OC3C(OC(CC3OC)OC4CC5=CCC6C(C5(CC4O)C)CCC7=COC8(C7C(CO8)OC6=O)C)C)C)OC)O
SMILES (Isomeric) C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@@H](O[C@H](C[C@@H]2OC)O[C@@H]3[C@H](O[C@H](C[C@@H]3OC)O[C@@H]4CC5=CC[C@@H]6[C@@H]([C@]5(C[C@H]4O)C)CCC7=CO[C@@]8([C@H]7[C@@H](CO8)OC6=O)C)C)C)OC)O
InChI InChI=1S/C42H64O15/c1-20-37(44)29(46-6)14-34(51-20)56-39-22(3)53-35(16-31(39)48-8)57-38-21(2)52-33(15-30(38)47-7)54-28-13-24-10-11-25-26(41(24,4)17-27(28)43)12-9-23-18-49-42(5)36(23)32(19-50-42)55-40(25)45/h10,18,20-22,25-39,43-44H,9,11-17,19H2,1-8H3/t20-,21-,22+,25-,26+,27-,28-,29+,30+,31+,32-,33+,34+,35+,36-,37-,38-,39-,41+,42+/m1/s1
InChI Key BOCRVBHCAQGQNQ-GEVWAFFVSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C42H64O15
Molecular Weight 808.90 g/mol
Exact Mass 808.42452133 g/mol
Topological Polar Surface Area (TPSA) 168.00 Ų
XlogP 2.30
Atomic LogP (AlogP) 3.66
H-Bond Acceptor 15
H-Bond Donor 2
Rotatable Bonds 9

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Tylophoside C

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9872 98.72%
Caco-2 - 0.8646 86.46%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.8323 83.23%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8441 84.41%
OATP1B3 inhibitior + 0.9719 97.19%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior + 0.9683 96.83%
P-glycoprotein inhibitior + 0.7565 75.65%
P-glycoprotein substrate + 0.7449 74.49%
CYP3A4 substrate + 0.7347 73.47%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8858 88.58%
CYP3A4 inhibition - 0.8476 84.76%
CYP2C9 inhibition - 0.9148 91.48%
CYP2C19 inhibition - 0.9613 96.13%
CYP2D6 inhibition - 0.9445 94.45%
CYP1A2 inhibition - 0.8823 88.23%
CYP2C8 inhibition + 0.5797 57.97%
CYP inhibitory promiscuity - 0.9502 95.02%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.4604 46.04%
Eye corrosion - 0.9902 99.02%
Eye irritation - 0.9158 91.58%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9385 93.85%
Ames mutagenesis - 0.6900 69.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7337 73.37%
Micronuclear - 0.7900 79.00%
Hepatotoxicity + 0.5448 54.48%
skin sensitisation - 0.8945 89.45%
Respiratory toxicity + 0.8000 80.00%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.7000 70.00%
Nephrotoxicity - 0.5839 58.39%
Acute Oral Toxicity (c) I 0.5334 53.34%
Estrogen receptor binding + 0.7979 79.79%
Androgen receptor binding + 0.7241 72.41%
Thyroid receptor binding - 0.5164 51.64%
Glucocorticoid receptor binding + 0.7613 76.13%
Aromatase binding + 0.6529 65.29%
PPAR gamma + 0.7622 76.22%
Honey bee toxicity - 0.6092 60.92%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.6100 61.00%
Fish aquatic toxicity + 0.9456 94.56%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 98.66% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.15% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.46% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 92.36% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.90% 89.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 91.22% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 90.53% 97.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 89.38% 99.23%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 88.86% 95.89%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.31% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.10% 95.56%
CHEMBL2581 P07339 Cathepsin D 87.46% 98.95%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 86.70% 96.77%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.66% 97.14%
CHEMBL253 P34972 Cannabinoid CB2 receptor 86.28% 97.25%
CHEMBL5255 O00206 Toll-like receptor 4 85.48% 92.50%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 85.02% 95.50%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 84.70% 97.33%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 84.65% 94.00%
CHEMBL226 P30542 Adenosine A1 receptor 84.02% 95.93%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 82.79% 95.71%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.74% 92.62%
CHEMBL255 P29275 Adenosine A2b receptor 80.38% 98.59%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.29% 86.33%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.18% 94.33%

Cross-Links

Top
PubChem 11803490
NPASS NPC107066
LOTUS LTS0184059
wikiData Q104939164